Skip to main content
Livermore
Livermore
ZHEN

Benjamin Edwards Inc

SEC CIK
0001451623
Latest filing
Jul 24, 2026

NTLA holding history

Intellia Therapeutics, Inc. in every 13F filed by Benjamin Edwards Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NTLA overviewAll 13F holders of NTLAFull Q2 2026 holdings

Shares (Q2 2026)
80,881
Value
$1.37M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of NTLA by Benjamin Edwards Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202680,881$1.37M<0.1%−1,682−2.0%ReducedHolders
Q1 202682,563$1.06M<0.1%+3,363+4.2%AddedHolders
Q4 202579,200$711.9K<0.1%+14,350+22.1%AddedHolders
Q3 202564,850$1.12M<0.1%+1,816+2.9%AddedHolders
Q2 202563,034$591.3K<0.1%+1,126+1.8%AddedHolders
Q1 202561,908$440.2K<0.1%−2,157−3.4%ReducedHolders
Q4 202464,065$746.9K<0.1%+6,396+11.1%AddedHolders
Q3 202457,669$1.18M<0.1%+57,253+13,762.7%AddedHolders
Q2 2024416$9.00K<0.1%−146−26.0%ReducedHolders
Q1 2024562$15.0K<0.1%+35+6.6%AddedHolders
Q4 2023527$16.0K<0.1%−317−37.6%ReducedHolders
Q3 2023844$27.0K<0.1%+78+10.2%AddedHolders
Q2 2023766$31.0K<0.1%+18+2.4%AddedHolders
Q1 2023748$28.0K<0.1%+38+5.4%AddedHolders
Q4 2022710$25.0K<0.1%+141+24.8%AddedHolders
Q3 2022569$32.0K<0.1%−44−7.2%ReducedHolders
Q2 2022613$32.0K<0.1%+6+1.0%AddedHolders
Q1 2022607$44.0K<0.1%−81−11.8%ReducedHolders
Q4 2021688$81.0K<0.1%+36+5.5%AddedHolders
Q3 2021652$87.0K0.1%−198−23.3%ReducedHolders
Q2 2021850$138.0K0.1%−443−34.3%ReducedHolders
Q1 20211,293$104.0K0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.